Coronavirus health insurance policies are available from PhonePe, Airtel app and MobiKwik.- The policy premium starts from ₹156 and gives a coverage of upto ₹50,000.
PhonePe, Digit and Bharti AXA General Insurance are among the companies that allow customers to get a dedicated
PhonePe
Online payment and wallet app PhonePe partnered with Bajaj Allianz General Insurance to offer a new Coronavirus insurance policy. This policy covers hospitalisation costs up to ₹50,000 for private hospitals, tests, medication and consultation for a period of 30 days before and after hospitalisation.
The PhonePe Coronavirus insurance has been priced at ₹156 and users will be eligible to claim insurance only if they are diagnosed 15 days after purchasing the policy.
Airtel and Bharti AXA Coronavirus Insurance
Airtel Payments Bank partnered with Bharti AXA General Insurance to offer a Coronavirus insurance policy that is applicable from day one. The fixed insurance sum is ₹25,000 and the premium is ₹499. If the policy holder is diagnosed negative after being quarantined for at least 14 days in a government hospital or military facility, they will be entitled to 50% of the sum insured.
Digit Coronavirus Insurance
Digit announced the Digit Health Plus Policy that covers the disease. The company has several policies to choose from, with policy amounts ranging from ₹25,000 to ₹2,00,000. The policy premium differs based on the policy selected and the age of the policy holder.
Digit also allows users to buy the Coronavirus insurance policy on MobiKwik. However, only three options were available on the app and a ₹3,00,000 option was available as well. On the app, the ₹50,000 policy is available for ₹406 premium, the ₹1.5 lakh policy is available for ₹746 and the ₹3 lakh policy is available for ₹1,267.
See also:
Life insurance policy holders get 30 days more to pay premium, amid the lockdown
India's 'Gods in white' get a ₹50 lakh insurance cover before protective masks
PhonePe partners Bajaj Allianz for hospitalisation insurance policy for COVID-19